http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2059415-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77230722f3bead86a47ee09a2713df0c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-265 |
| filingDate | 1992-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1996-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7758aa6ddee1d60a0e1804e7cbfa20d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f0515881d78c11b0c194d626f6a0f37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46ee00ae88d603ea92b20a7730f0c622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3499458e19db9806299b39195956719 |
| publicationDate | 1996-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2059415-C1 |
| titleOfInvention | Inactivated vaccine against infectious rhinotracheitis in cattle |
| abstract | FIELD: veterinary. SUBSTANCE: vaccine has concentrated antigen of infectious rhinotracheitis virus from the strain Herpesvirus bovis 1 obtained in cattle cell cultures and vaccine contains, vol.%: concentrated antigen of infectious rhinotracheitis virus 50-90, and oily adjuvant - the rest. Vaccine is administrated intracutaneously (0.2-0.4 ml) or subcutaneously (2.0-6.0 ml) two-fold at 14-21 days interval to calves at the age 30 days and older. Vaccine provides expressing immunity in cattle to infectious rhinotracheitis. EFFECT: harmless high-immunogenic vaccine. 2 tbl |
| priorityDate | 1992-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.